Business

Resverlogix Commends Dr. William Cochrane's Induction into the Canadian Medical Hall of Fame

Resverlogix Commends Dr. William Cochrane's Induction into the Canadian Medical Hall of Fame

articleResverlogix Corp.October 26, 20094/company/resverlogix-corp/news/resverlogix-commends-dr-william-cochranes-induction-into-the-canadian-medical-hall-of-fame
Resverlogix Commends Dr. William Cochrane's Induction into the Canadian Medical Hall of Fame

About this update from Resverlogix Corp.

[{"type":"text","content":"\n\n\n\nOct. 26, 2009 (Canada NewsWire Group) -- CALGARY, Oct. 26 /CNW/ -- Resverlogix Corp. (\"Resverlogix\" or the \"Company\") (TSX:RVX) congratulates Dr. William Cochrane, OC, MD, FRCPC, FACP, DABP, Chairman of Resverlogix's Board of Directors, who was recently announced as one of six medical pioneers inducted into the Canadian Medical Hall of Fame. Dr. Cochrane will join 76 Hall of Fame laureates who have been inducted for their work which pushed the boundaries of knowledge to advance human health. Previous appointees include Dr. Frederick Banting and Dr. Charles Best the co-founders of insulin; as well as Dr. Michael Smith for his discovery of site directed mutagenesis and Dr. Jacques Genest a preeminent researcher of the cause and treatment of high blood pressure, to name a few.Dr. Cochrane was recognized early on as a leader in pediatrics, Dr. Cochrane's career evolved through medical research, medical education, biotechnology and business. A visionary who never gave up, Dr. Cochrane had an extraordinary ability to attract and encourage others to join him in his pursuit for excellence in Canadian medicine. As a pediatrician, Dr. Cochrane was one of the first non-hospital sub-specialists to practice in Ontario. His research interests led to the development of an acetone tolerance test to diagnose glycogen storage disease of the liver (1953) and to the Cochrane (L-leucine) test still in use today to identify a form of hypoglycemia that is sensitive to protein intake (1956).Deciding to move to Calgary Dr. Cochrane arrived with limited resources, to develop a medical school at the University of Calgary. Attracted by the opportunity to start afresh, he introduced a systems-based approach to teaching medicine and began one of only two three-year MD training programs in North America. Several successful ventures followed including becoming Alberta's Deputy Minister of Health (1973-1974). As President of the University of Calgary (1974-1978) he established Faculties of Humanities and Law. Moving into the realm of business, as Chairman and CEO of Connaught Laboratories (1978-1989), Dr. Cochrane championed a new strategy for the company that focused on genetic engineering. He also sat on 30 Boards of corporations ranging from biotechnology to real estate, in addition to being a dedicated community leader.Among numerous awards, Dr....

More updates from Resverlogix Corp.